Mathematical modeling of cancer invasion: The role of membrane-bound matrix metalloproteinases

Frontiers in Oncology

Volumn 3 APR, Issue , 2013, Pages

  Deakin, Niall E ^a   Chaplain, Mark A J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer invasion; Extracellular matrix; Mathematical model; Membrane bound MMPs; Metalloproteinases

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL; CELL DENSITY; COLORECTAL CANCER; COMPUTER SIMULATION; EXTRACELLULAR MATRIX; MATHEMATICAL MODEL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR MICROENVIRONMENT;

EID: 84890653380     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00070     Document Type: Article

References (43)

1. Anderson, A. R. A., Chaplain, M. A. J., Newman, E. L., Steele, R. J. C., and Thompson, A. M. (2000). Mathematical modelling of tumour invasion and metastasis. Comput. Math. Methods Med. 2, 129-154.
2. Araujo, R. P., and McElwain, D. L. S. (2004). A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull. Math. Biol. 66, 1039-1091.
3. Burton, A. C. (1966). Rate of growth of solid tumours as a problem of diffusion. Growth 30, 157-176.
4. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., Schade van Westrum, S., et al. (1998). The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A: a kinetic study. J. Biol. Chem. 273, 871-880.
5. Collier, I. E., Legant, W., Marmer, B., Lubman, O., Saffarian, S., Wakatsuki, T., et al. (2011). Diffusion of MMPs on the surface of collagen fibrils: the mobile cell surface-collagen substratum interface. PLoS ONE 6:e24029. doi:10.1371/journal.pone.0024029
6. Donzé, A., Fanchon, E., Gattepaille, L. M., Maler, O., and Tracqui, P. (2011). Robustness analysis and behavior discrimination in enzymatic reaction networks. PLoS ONE 6:e24246. doi:10.1371/journal.pone.0024246
7. d'Ortho, M. P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., et al. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751.
8. English, W. R., Holtz, B., Vogt, G., Knauper, V., and Murphy, G. (2001). Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases. J. Biol. Chem. 276, 42018-42026.
9. Friedl, P., and Wolf, K. (2003). Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp. 70, 277-285.
10. Gerisch, A., and Chaplain, M. A. (2008). Mathematical modelling of cancer cell invasion of tissue: local and non-local models and the effect of adhesion. J. Theor. Biol. 250, 684-704.
11. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
12. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
13. Hoshino, D., Koshikawa, N., Suzuki, T., Quaranta, V., Weaver, A. M., Seiki, M., et al. (2012). Establishment and validation of computational model for MT1-MMP dependent ECM degradation and intervention strategies. PLoS Comput. Biol. 8:e1002479. doi:10.1371/journal.pcbi.1002479
14. Ichikawa, K. (2001). A-Cell: graphical user interface for the construction of biochemical reaction models. Bioinformatics 17, 483-484.
15. Karagiannis, E. D., and Popel, A. S. (2004). A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2. J. Biol. Chem. 279, 39105-39114.
16. Karagiannis, E. D., and Popel, A. S. (2006). Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. J. Theor. Biol. 238, 124-145.
17. Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
18. Kinoh, H., Sato, H., Tsunezuka, Y., Takino, T., Kawashima, A., Okada, Y., et al. (1996). MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell. Sci. 109, 953-959.
19. Kleiner, D. E., and Stetler-Stevenson, W. G. (1999). Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43(Suppl.), 42-51.
20. Lafleur, M. A., Tester, A. M., and Thompson, E. W. (2003). Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett. 553, 457-463.
21. Li, X. Y., Ota, I., Yana, I., Sabeh, F., and Weiss, S. J. (2008). Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase. Mol. Biol. Cell 19, 3221-3233.
22. López-Otín, C., and Overall, C. M. (2002). Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3, 509-519.
23. Lowengrub, J. S., Frieboes, H. B., Jin, F., Chuang, Y. L., Li, X., Macklin, P., et al. (2010). Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23, R1-R9.
24. Martins, V. L., Vyas, J. J., Chen, M., Purdie, K., Mein, C. A., South, A. P., et al. (2009). Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J. Cell. Sci. 122(Pt 11), 1788-1799.
25. Nagase, H., and Woessner, J. F. (1999). Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
26. Nishida, Y., Miyamori, H., Thompson, E. W., Takino, T., Endo, Y., and Sato, H. (2008). Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Cancer Res. 68, 9096-9104.
27. Nöel, A., Gutiérrez-Fernández, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I. K., et al. (2012). New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front. Pharmacol. 3:140. doi:10.3389/fphar.2012.00140
28. Nyström, M. L., Thomas, G. J., Stone, M., Mackenzie, I. C., Hart, I. R., and Marshall, J. F. (2005). Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J. Pathol. 205, 468-475.
29. Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Knittel, J. G., Yan, L., Rueden, C. T., et al. (2008). Collagen density promotes mammary tumor initiation and progression. BMC Med. 6:11. doi:10.1186/1741-7015-6-11
30. Rejniak, K. A., and McCawley, L. J. (2010). Current trends in mathematical modeling of tumor-microenvironment interactions: a survey of tools and applications. Exp. Biol. Med. (Maywood) 235, 411-423.
31. Rowe, R. G., and Weiss, S. J. (2009). Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu. Rev. Cell Dev. Biol. 25, 567-595.
32. Sabeh, F., Shimizu-Hirota, R., and Weiss, S. J. (2009). Protease-dependent versus-independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185, 11-19.
33. Sahai, E. (2005). Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15, 87-96.
34. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338.
35. Tam, E. M., Moore, T. R., Butler, G. S., and Overall, C. M. (2004). Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279, 43336-43344.
36. Thomlinson, R. H., and Gray, L. H. (1955). The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539-549.
37. Toth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z., Bigg, H. F., et al. (2000). Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J. Biol. Chem. 275, 41415-41423.
38. Trucu, D., Lin, P., Chaplain, M., and Wang, Y. (2013). A multiscale moving boundary model arising in cancer invasion. Multiscale Model. Simul. 11, 309-335.
39. Tutton, M. G., George, M. L., Eccles, S. A., Burton, S., Swift, R. I., and Abulafi, A. M. (2003). Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int. J. Cancer 107, 541-550.
40. Werb, Z. (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439-442.
41. Wolf, K., Alexander, S., Schacht, V., Coussens, L. M., von Andrian, U. H., van Rheenen, J., et al. (2009). Collagen-based cell migration models in vitro and in vivo. Semin. Cell Dev. Biol. 20, 931-941.
42. Zhang, Y., Mao, X., Schwend, T., Littlechild, S., and Conrad, G. W. (2013). Resistance of corneal RFUVA-cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 54, 1014-1025.
43. Zigrino, P., Drescher, C., and Mauch, C. (2001). Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins. Eur. J. Cell Biol. 80, 68-77.